Another study has postulated the role of eGFR as a covariate for total clearance in the accurate prediction of gabapentin pharmacokinetics irrespective of the glycemic status of patients with diabetic peripheral neuropathy, radiculopathies or different genetic variants of OCTN1 rs1050152 [10]. Here, SLC22A4 is linked to radiculopathy.